Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation. 
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy01:26

Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy

Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient-Reported Outcomes in Clinical Trials of Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026
Same author

The Inflammatory Bowel Disease in South-Eastern Norway study: three decades of advancements in clinical understanding and scientific partnerships.

Therapeutic advances in gastroenterology·2026
Same author

Multi-centered T cell repertoire profiling identifies alterations in the immune repertoire of individuals with inflammatory bowel disease across different disease stages.

Genome medicine·2026
Same author

High-dose intravenous iron improves quality of life in patients with inflammatory Bowel disease and iron deficiency.

Scandinavian journal of gastroenterology·2026
Same author

Long-Term Disease Course of Crohn's Disease in a Prospective European Population-Based Inception Cohort: An Epi-IBD Cohort Study.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2025
Same author

Long-Term Safety of Vedolizumab in Patients With Ulcerative Colitis/Crohn's Disease: A Prospective Observational Study.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2025

Related Experiment Video

Updated: Jul 14, 2026

Murine Distal Colostomy, A Novel Model of Diversion Colitis in C57BL/6 Mice
08:20

Murine Distal Colostomy, A Novel Model of Diversion Colitis in C57BL/6 Mice

Published on: July 12, 2018

Low colectomy rates in ulcerative colitis in an unselected European cohort followed for 10 years.

Ole Hoie1, Frank L Wolters, Lene Riis

  • 1Sorlandet Hospital Arendal, Department of Medicine, Section for Gastroenterology, Arendal, Norway. olehoeie@online.no

Gastroenterology
|January 30, 2007
PubMed
Summary

The 10-year colectomy risk in ulcerative colitis (UC) is 8.7%, varying significantly between Northern (10.4%) and Southern Europe (3.9%). Extensive colitis increased colectomy likelihood, but geographic variations remain unexplained.

More Related Videos

Colonial Wig Pancreaticojejunostomy
07:49

Colonial Wig Pancreaticojejunostomy

Published on: March 12, 2019

Caudal-to-cranial Approach in Laparoscopic Right Hemicolectomy with Complete Mesocolon Excision and D3 Lymph Node Dissection
06:46

Caudal-to-cranial Approach in Laparoscopic Right Hemicolectomy with Complete Mesocolon Excision and D3 Lymph Node Dissection

Published on: January 9, 2026

Related Experiment Videos

Last Updated: Jul 14, 2026

Murine Distal Colostomy, A Novel Model of Diversion Colitis in C57BL/6 Mice
08:20

Murine Distal Colostomy, A Novel Model of Diversion Colitis in C57BL/6 Mice

Published on: July 12, 2018

Colonial Wig Pancreaticojejunostomy
07:49

Colonial Wig Pancreaticojejunostomy

Published on: March 12, 2019

Caudal-to-cranial Approach in Laparoscopic Right Hemicolectomy with Complete Mesocolon Excision and D3 Lymph Node Dissection
06:46

Caudal-to-cranial Approach in Laparoscopic Right Hemicolectomy with Complete Mesocolon Excision and D3 Lymph Node Dissection

Published on: January 9, 2026

Area of Science:

  • Gastroenterology
  • Clinical Epidemiology
  • Surgical Outcomes

Background:

  • Ulcerative colitis (UC) colectomy rates impact morbidity and treatment.
  • Understanding colectomy risk and influencing factors is crucial for patient management.

Purpose of the Study:

  • To determine the 10-year colectomy risk in ulcerative colitis (UC) patients post-diagnosis.
  • To identify factors influencing the decision for surgical treatment in UC.

Main Methods:

  • Prospective inception cohort study of 781 UC patients across 9 centers in Europe and Israel (1991-1993).
  • 10-year follow-up assessing colectomy rates and associated factors.
  • Analysis included 617 patients with complete records after accounting for deaths and loss to follow-up.

Main Results:

  • The 10-year cumulative colectomy risk was 8.7%, with higher rates in Northern Europe (10.4%) vs. Southern Europe (3.9%).
  • Extensive colitis significantly increased colectomy likelihood (HR 4.1), while proctitis had lower rates.
  • Geographic variations in colectomy rates were observed, with higher adjusted HRs for The Netherlands/Norway (2.7) and Denmark (8.2) compared to southern centers.

Conclusions:

  • The overall colectomy rate in UC is lower than previously reported.
  • Significant geographic disparities in colectomy rates exist between Northern and Southern Europe.
  • While extensive colitis is linked to colectomy, the reasons for geographic variations are not explained by diagnosis-related factors.